Kotak Smallcap Fund
The scheme seeks to generate capital appreciation from a diversified portfolio of equity and equity related securities by investing predominantly in small cap companies.
Growthvine rating: 1/5 — ranked #35 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹274.20 (as of 2026-09-11) |
|---|
| AUM | ₹18,933 Cr |
|---|
| Expense ratio | 1.42% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Harish Bihani |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 12.65% |
|---|
| Sharpe ratio | 0.38 |
|---|
| Standard deviation | 19.38% |
|---|
| Max drawdown | -70.41% |
|---|
| Alpha | -1.88 |
|---|
| Beta | 0.86 |
|---|
Over 5 years, captured 77.0% of NIFTY Smallcap 250's upside and 76.5% of its downside.
Market cap allocation
| Large cap | 7.2% |
|---|
| Mid cap | 18.1% |
|---|
| Small cap | 74.7% |
|---|
Concentration
| Top 5 holdings | 18.5% |
|---|
| Top 10 holdings | 29.7% |
|---|
| Total holdings | 79 |
|---|
| Index overlap | 13.1% |
|---|
| Active share | 86.9% |
|---|
Top holdings
- Aster DM Healthcare Limited — 4.9%
- Vijaya Diagnostic Centre Limited — 3.9%
- Sansera Engineering Limited — 3.7%
- Krishna Institute of Medical Sciences Limited — 3.6%
- Century Plyboards (India) Ltd. — 2.5%
- Minda Corporation Limited — 2.5%
- KALPATARU PROJECTS INTERNATIONAL LIMITED — 2.4%
- Five-Star Business Finance Ltd. — 2.3%
- Ajanta Pharma Ltd. — 2.1%
- ICICI Bank Ltd. — 2.0%
Top sectors
- Healthcare — 14.8%
- Retail — 11.5%
- Consumer Durables — 9.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 9.8% | Q3 | #25 of 34 |
| 2025 | -9.1% | Q4 (Bottom) | #27 of 30 |
| 2024 | 25.5% | Q2 | #14 of 28 |
| 2023 | 34.8% | Q4 (Bottom) | #19 of 24 |
| 2022 | -3.1% | Q3 | #17 of 22 |